We are live on ! Find out more
VSEEW

VSee Health Warrant
VSEEW

25 hedge funds and large institutions have $543K invested in VSee Health Warrant in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

31.25% more ownership

Funds ownership: 0% → 31.25% (+31%)

4% more funds holding

Funds holding: 24 → 25 (+1)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

82% less capital invested

Capital invested by funds: $3.01M → $543K (-$2.46M)

Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
5
Closed
2
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$57K

Top Buyers

Rank Fund Capital Flow
1
ASM
ATW SPAC Management
New York
+$25.7K
2
CAC
Cowen and Company
New York
+$15K
3
CS
Clear Street
New York
+$5.41K
4
Goldman Sachs
Goldman Sachs
New York
+$4.33K
5
TSS
Two Sigma Securities
New York
+$1.88K

Top Sellers

Rank Fund Capital Flow
1
KL
KIM LLC
Kansas
-$43.3K
2
SCM
Shaolin Capital Management
Florida
-$19.8K
3
AA
AQR Arbitrage
Connecticut
-$4.78K
4
KAS
Kestra Advisory Services
Texas
-$2.16K
5
WAM
Wolverine Asset Management
Illinois
-$1.84K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$353K – – –
LA
2
Linden Advisors
New York
$28.9K – – –
MI
3
MMCAP International
Cayman Islands
$20K – – –
EAM
4
Exos Asset Management
New York
$19.6K – – –
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$15K – – –
SCM
6
Saba Capital Management
New York
$14.4K – – –
CS
7
Clear Street
New York
$12.8K +$5.41K +50,000 +19%
AIMCA
8
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$10K – – –
WA
9
Whitebox Advisors
Minnesota
$10K – – –
CAC
10
Cowen and Company
New York
$9.56K +$15K +139,039 +139%
ASM
11
ATW SPAC Management
New York
$9.49K +$25.7K +237,179 New
YCM
12
Yakira Capital Management
Connecticut
$8.46K – – –
ACM
13
Altium Capital Management
New York
$6K – – –
CSD
14
Clear Street Derivatives
New York
$6K – – –
QCIG
15
Quad-Cities Investment Group
Iowa
$4.84K – – –
AA
16
AQR Arbitrage
Connecticut
$4.53K -$4.78K -44,140 -28%
RCM
17
Rivernorth Capital Management
Florida
$3K – – –
WAM
18
Wolverine Asset Management
Illinois
$2.26K -$1.84K -17,046 -23%
Goldman Sachs
19
Goldman Sachs
New York
$1.6K +$4.33K +40,050 New
Citadel Advisors
20
Citadel Advisors
Florida
$829 -$173 -1,598 -7%
AA
21
Ancora Advisors
Ohio
$788 – – –
TSS
22
Two Sigma Securities
New York
$696 +$1.88K +17,400 New
SCM
23
Shaolin Capital Management
Florida
$685 -$19.8K -182,885 -91%
UBS Group
24
UBS Group
Switzerland
$218 -$102 -942 -15%
Bank of America
25
Bank of America
North Carolina
$16 +$11 +100 +33%
1
2

VSEEW Hedge Fund Activity: Q3 2024 in Review

25 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in VSee Health Warrant (VSEEW) for Q3 2024, worth a combined $543K — down 82% from $3.01M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new VSEEW positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 5 trimmed.

The largest buyer was ATW SPAC Management, opening a new position worth an estimated $25.7K. The largest seller was KIM LLC, exiting entirely with an estimated $43.3K sold.

  • 25 institutional investors held VSee Health Warrant (VSEEW) as of Q3 2024, up from 24 in Q2 2024.
  • Funds reported $543K of VSee Health Warrant stock for Q3 2024, down 82% quarter-over-quarter.
  • 3 funds opened new VSee Health Warrant positions in Q3 2024 and 2 closed out, a net change of +1 holder.
  • The largest VSee Health Warrant buyer in Q3 2024 was ATW SPAC Management, an estimated $25.7K added.
  • The largest VSee Health Warrant seller in Q3 2024 was KIM LLC, an estimated $43.3K sold.

Based on aggregated 13F filings for Q3 2024.